Humana (NYSE: HUM) Earnings Q3 2010


View Humana's (NYSE: HUM) Q3 Earnings Report


  • Earnings per share for 3Q 2010 totaled $2.32, included $0.31 of favorable prior-period medical claims development
  • 2010 EPS guidance raised to range of $6.40 to $6.50
  • Strong operating performance in both business segments
  • YTD cash flows from operations exceeded $2.2 billion
  • TRICARE contract expected to be extended through March 2012

Check out Humana's current earnings estimates from CNN Money

See how HUM is performing right now

Humana's website:

Suggested Articles

Outpatient specialty drugs can be a lucrative income source for not-for-profit hospitals, but Washington presents some risks, Moody's says.

The growing role of data in our lives raises important questions about data access and ownership. Who rightfully owns the data?

Anthem posted $1.18 billion in third-quarter profit, an increase of 23% over the prior-year quarter.